Igor Moura de Paiva (Igor M Paiva)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Tyrosine Kinase

Top Venues

Molecular pharmaceutics

University of Alberta

University of Alberta (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Alberta

Canada

Posdoc Fellow :: Pharmacy and Pharmaceutical Sciences

Education History

University of Alberta Sep 3o 2014 - Feb 5o 2020

Canada

PHD :: Pharmacy and Pharmaceutical Sciences

Publications

Elmira Ziaei, Igor Moura de Paiva, Shih-Jing Yao, Nasim Sarrami, Parnian Mehinrad, Justine Lai, Afsaneh Lavasanifar, Kamaljit Kaur
Peptide-Drug Conjugate Targeting Keratin 1 Inhibits Triple-Negative Breast Cancer in Mice. Molecular pharmaceutics (2023)
Igor Moura de Paiva
Voices in Molecular Pharmaceutics: Meet Dr. Igor Moura de Paiva, on a Mission to Tackle Cancer Through Evidence-Based Medicine. Molecular pharmaceutics 19 (6) (2022)
Igor Moura de Paiva, Mohammad Reza Vakili, Amir Hasan Soleimani, Seyed Amirhossein Tabatabaei Dakhili, Sirazum Munira, Marco Paladino, Gary Martin, Frank R Jirik, Dennis G Hall, Michael Weinfeld, Afsaneh Lavasanifar
Biodistribution and Activity of EGFR Targeted Polymeric Micelles Delivering a New Inhibitor of DNA Repair to Orthotopic Colorectal Cancer Xenografts with Metastasis. Molecular pharmaceutics 19 (6) (2022)
Sams M A Sadat, Mohammad Reza Vakili, Igor Moura de Paiva, Michael Weinfeld, Afsaneh Lavasanifar
Development of Self-Associating SN-38-Conjugated Poly(ethylene oxide)-Poly(ester) Micelles for Colorectal Cancer Therapy. Pharmaceutics 12 (11) (2020)